Ledger.Open graph →
SEC Form D · filed December 21, 2022

Protillion Biosciences, lnc

Offering
$20.7M
Sold
$19.0M
Exemption
Rule 506(b)
Industry
Other
Location
BURLINGAME, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

David Walt · Cambridge, MADirectorMalek Faham · Burlingame, CADirectorSean Kendall · Burlingame, CADirectorCurtis Layton · Burlingame, CAExec · DirectorSean Kendall · Burlingame, CADirectorDavid Walt · Cambridge, MADirectorMalek Faham · Menlo Park, CADirectorCurtis Layton · Burlingame, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗